FindTrial
Sign In

Lansoprazole 15 mg

DRUG6 trials

Sponsors

Daewoong Pharmaceutical Co. LTD., HK inno.N Corporation, Daejeon St. Mary's hospital, Addpharma Inc.

Conditions

Coronary Artery DiseaseGastro Esophageal RefluxHealed Erosive EsophagitisNSAID (Non-Steroidal Anti-Inflammatory Drug)Peptic UlcerPreventive Peptic Ulcer

Phase 1

A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121
CompletedNCT06025773
Addpharma Inc.Gastro Esophageal Reflux
Start: 2023-09-15End: 2024-04-19Updated: 2024-08-01

Phase 3

Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis
NCT04341428
Daewoong Pharmaceutical Co. LTD.Healed Erosive Esophagitis
Start: 2020-07-02End: 2021-12-30Target: 406Updated: 2020-09-03
Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
CompletedNCT04784910
Daewoong Pharmaceutical Co. LTD.Peptic Ulcer
Start: 2021-05-21End: 2023-12-11Updated: 2024-07-08
Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs
NCT04840550
HK inno.N CorporationPreventive Peptic Ulcer
Start: 2021-05-07End: 2024-07-31Target: 390Updated: 2023-07-14

Phase 4

The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)
NCT05820048
Daejeon St. Mary's hospitalCoronary Artery Disease
Start: 2023-05-01End: 2025-07-31Target: 300Updated: 2023-04-19
Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer
Not yet recruitingNCT07533266
Daewoong Pharmaceutical Co. LTD.NSAID (Non-Steroidal Anti-Inflammatory Drug)
Start: 2026-04-01End: 2027-12-01Target: 360Updated: 2026-04-16

Related Papers

Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Peptic Ulcer
Gut and Liver2025-06-262 citations